8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Jan 20, 2026 · 5mo ago · Accession 0001104659-26-004795
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Corvus Pharmaceuticals, Inc.
- Ticker
- CRVS
- CIK
- 1626971
- Form type
- 8-K
- Filing date
- Jan 20, 2026
- Report date
- Jan 20, 2026
- Document
- tm263501d4_8k.htm
- Size
- 2.4 MB